首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Last year, when President George W. Bush announced that federal funds could be used to support research on human embryonic stem
Last year, when President George W. Bush announced that federal funds could be used to support research on human embryonic stem
admin
2016-01-30
91
问题
Last year, when President George W. Bush announced that federal funds could be used to support research on human embryonic stem cells, he mandated that only those cell lines that existed at the time would qualify for such support. More than a year later, it’s becoming increasingly clear that these existing cell lines are inadequate. Unless more are created, the research slowdown may exact a staggering cost in terms of human suffering.
Since this announcement, the US National Institutes of Health has tried to stimulate research on. the existing cell lines with new funding and efforts to streamline the initially cumbersome process of obtaining approved cells. However, whether there are 60 cell lines, as originally stated, or nine, as now appear to be available to NIH-funded investigators, the number is not adequate. Given the genetic diversity within the population, scientists need access to new cell lines if they are to come up with the most effective cell therapies.
The issue is partly one of safety. In conducting research with human participants, we must minimize risks. The most effective cell line might not be the safest. When developing a new medicine, a large number of molecules must be screened to find a balance between effectiveness and safety. The same is true with cells. In the context of cell therapy, it will be important to minimize unwanted immune reactions and inflammation this requires selection from a large number of cell lines to obtain the best match.
It’s clear from experiments with animals that stem-cell therapies can reduce human suffering as Parkinsonian mice have been cured with embryonic stem cells that were programmed to become dopamine-secreting, replacement nerve ceils. Soon, cells induced to make insulin in tissue cultures will be used in attempts to treat diabetic mice. Similar successes have been achieved in animal models of spinal-cord injury, heart failure and other degenerative disorders. We are at a frontier in medicine where tissues will be restored in ways that were not imaginable just a few years ago. The ethical issues raised by human-embryo research are profound. The human costs of restricting this research must be taken into account as well. The cost in dollars of delaying new stem-cell research is difficult to estimate. It might measure in the hundreds of billions of dollars, especially if one adds the lost productivity of individuals who must leave work to care for victims of degenerative disorders.
A less obvious, but real, cost is the damage to the fabric of America’s extraordinary culture of inquiry and technical development in biomedical science. Our universities and teaching hospitals are unparalleled. We attract the very best students, scientists and physicians from around the world. But these institutions are fragile. Research and education play key roles in attracting the best physicians. A crippled research enterprise might add an unbearable stress with long-lasting effects on the entire system. If revolutionary new therapies are delayed or outlawed, we could be set back for years, if not decades.
To steer clear of controversy, some investigators will redirect their research. Others will emigrate to countries where such research is allowed and encouraged. Some will drop out entirely. The pall cast over the science community could extend far beyond stem-cell research. Many therapies have emerged from collaboration between government-sponsored researchers and private enterprise. Few of these discoveries would have emerged if, for instance, recombinant DNA research had been outlawed 30 years ago. We face the same type of decision today with limits placed on human embryonic stem cells. Safeguards will be necessary. But if we do not proceed embracing the values of objective, open, inquiry with complete sharing of methods and results, the field will be left to less rigorous fringe groups here and abroad. Patients and society will suffer.
The word "streamline" in Paragraph 2 probably means______.
选项
A、strengthen
B、simplify
C、ascertain
D、subvert
答案
B
解析
语义题。根据题干定位到原文第二段首句。其中cumbersome表示“讨厌的,麻烦的,笨重的”。既然原来的过程是很繁琐的,那需要做的就是简化这一过程。故答案为B。
转载请注明原文地址:https://kaotiyun.com/show/8FGO777K
0
考博英语
相关试题推荐
(浙江大学2009年试题)Teachersneedtobeawareoftheemotional,intellectual,andphysicalchangesthatyoungadultsexperience,a
(浙江大学2009年试题)Teachersneedtobeawareoftheemotional,intellectual,andphysicalchangesthatyoungadultsexperience,a
Whenmostpeoplethinkaboutchangingtheirbodyshape,theyusuallyfocusonjustlosingweight.Booksandmagazinesaboutdiet
Althoughthestudyofgeneticsisanentirelynewfield,it______mankindformanyyears.
Today,theTowerofLondonisoneofthemostpopulartourist【C1】______andattractsoverthreemillionvisitorsayear.Itw
______touchinginO’Henry’sstoriesisthegallantrywithwhichordinarypeoplestruggletomaintaintheirdignity.
Customhasnotbeencommonlyregardedasasubjectofanygreatmoment.Theinnerworkingsofourownbrainswefeeltobeuniqu
Aschildrenwestart【C1】______anaturalcuriosityabouteverythingaroundus,andduringthematurationprocessthiscuriosityc
Publicspeakingfillsmostpeoplewithdread.Humiliationisgreatestfear;self-exposureandfailingtoappealtotheaudience
Wateristhegiverand,atthesametime,thetakeroflife.Itcoversmostofthesurfaceoftheplanetweliveonandfeatures
随机试题
会计科目在年度中间进行调整时,进行结转一律()。
(2012年4月)1956年至1957年,中国共产党人探索社会主义建设道路取得的积极成果有________、________、________、________。
确定某因素与疾病可能存在因果关系时,哪种说法是不正确的
关于细胞因子()
下列蛋白质通过凝胶层析柱时最先被洗脱的是
男,10岁,突发剑突下剧烈绞痛1小时,疼痛呈钻顶样,辗转不安。查体:腹肌柔软,右上腹部轻微压痛,首先考虑的诊断是
平面4x-6x+7=0的位置是()。
案例【背景资料】A公司承建跨线立交桥工程,桥梁全长782.4m,共计26跨,桥梁下部结构有240根直径1.2m的钻孔灌注桩,采用反循环钻机成孔。项目部经招标程序将钻孔作业分项工程分包给B公司,签订了分包合同。施工过程中现场发生如下事件:
下列关于夫妻共同债务的说法中,不正确的是()。
决定需求的首要因素是()。
最新回复
(
0
)